Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 19/20 | 0.64 |
| ▸ | PARP2 | Q9UGN5 | 10/20 | 0.64 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.63 |
| ▸ | CSF1R | P07333 | 2/20 | 0.63 |
| ▸ | PIM1 | P11309 | 2/20 | 0.63 |
| ▸ | CLK2 | P49760 | 2/20 | 0.63 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.63 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.63 |
| ▸ | MINK1 | Q8N4C8 | 2/20 | 0.63 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.63 |
| ▸ | MAP4K5 | Q9Y4K4 | 2/20 | 0.63 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.63 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.63 |
| ▸ | INSR | P06213 | 1/20 | 0.63 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.63 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.63 |
| ▸ | MELK | Q14680 | 1/20 | 0.63 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.63 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.63 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4969237 | 0.89 | PARP1 (0.65) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL4971956 | 0.87 | PARP1 (0.61) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL4975669 | 0.86 | PARP1 (0.75) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL21160643 | 0.86 | PARP1 (0.75) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL9988497 | 0.86 | PARP1 (0.66) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL4971044 | 0.85 | PARP1 (0.66) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL4971680 | 0.85 | PARP1 (0.65) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL5520570 | 0.84 | PARP1 (0.63) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL4974172 | 0.82 | PARP1 (0.74) | PARP1PARP2MAP4K4CSF1RPIM1 | |
| SCHEMBL4969958 | 0.81 | PARP1 (0.72) | PARP1PARP2MAP4K4CSF1RPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210299137-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES | CYBREXA 1, INC. | 2021-09-30 | — | — | US | disclosed |
| US-10933069-B2 | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | CYBREXA 1, INC. (US) | 2021-03-02 | — | — | US | disclosed |
| US-20190209580-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES | CYBREXA 1, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299137-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES | HIF1A, HIF1AN, VHL | PARP1 1881/4885PARP2 1429/4885MAP4K4 2937/4885 |
| US-10933069-B2 | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | HIF1A, HIF1AN, VHL | PARP1 1881/4885PARP2 1429/4885MAP4K4 2937/4885 |
| US-20190209580-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES | HIF1A, HIF1AN, VHL | PARP1 1881/4885PARP2 1429/4885MAP4K4 2937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.